Displaying 121 - 140 of 1386
Elanco Animal Health and Bayer Animal Health; Analysis of Agreement Containing Consent Orders To Aid Public Comment
FTC to Host Virtual PrivacyCon 2020 on July 21
SuperGoodDeals.com, Inc.
The FTC filed a complaint against SuperGoodDeals.com, Inc. and its owner, Kevin J. Lipsitz, alleging that the defendants falsely promised consumers next-day shipping of facemasks and other personal protective equipment (PPE) to deal with the coronavirus pandemic. In addition, the FTC alleged that some of the other merchandise sold through the SuperGoodDeals website were falsely advertised as “authentic” or “certified.”
Statement of Commissioner Rebecca Kelly Slaughter Concerning the Contact Lens Rule
FTC Comment Supports Provisions in Centers for Medicare & Medicaid Services’ Interim Final Rule that Reduce or Eliminate Restrictive Medicare Payment Requirements for Telehealth and Related Services during Pandemic
FTC Approves Final Order Settling Charges that Danaher Corporation’s Acquisition of GE Biopharma Was Anticompetitive
FTC Approves Final Order Imposing Conditions on Össur Hf’s Acquisition of College Park Industries, Inc.
Össur Hf. and College Park Industries, In the Matter of
Össur Hf and College Park Industries, Inc., both makers of prosthetic limbs, have agreed to divest College Park’s myoelectric elbow business to settle Federal Trade Commission charges that Össur’s proposed acquisition of College Park would violate federal antitrust law.
16 CFR Part 318: Health Breach Notification Rule; Request for Public Comment
Wilson says pandemic underscores need to establish privacy rules for 'Big Tech'
FTC Alerts Consumers About Nursing Homes and Assisted Living Facilities Taking Stimulus Checks From Medicaid Patients
AbbVie Inc. and Allergan plc; Analysis of Consent Order To Aid Public Comment
AbbVie Inc. and Allergan plc, In the Matter of
Pharmaceutical companies AbbVie Inc. and Allergan plc have agreed to divest assests to settle Federal Trade Commission charges that AbbVie's proposed $63 billion acquisition of Allergan would violate federal antitrust law. On Sept. 4, 2020, the Commission announced the final consent agreement in this matter.
AH Media Group, LLC
In September 2019, the operators of a deceptive negative option scheme agreed to a court-ordered preliminary injunction temporarily barring them from a wide range of conduct. The preliminary injunction stops the defendants from misleading consumers about supposedly “free trial” offers, enrolling them in unwanted continuity plans, billing them without their authorization, and making it nearly impossible for them to cancel or get their money back.
Statement of Chairman Joseph J. Simons, Commissioner Noah J. Phillips and Commissioner Christine S. Wilson Concerning the Proposed Acquisition of Allergan plc by AbbVie Inc.
Dissenting Statement of Commissioner Rohit Chopra In the Matter of AbbVie Inc. and Allergan plc
Dissenting Statement of Commissioner Rebecca Kelly Slaughter Regarding the Proposed Acquisition of Allergan plc by AbbVie Inc.
Displaying 121 - 140 of 1386